Artemis Medicare Reports FY26 Profit Up 21% to ₹103.7 Cr, Proposes Dividend

Artemis Medicare Services Ltd announced its audited financial results for the fiscal year ended March 31, 2026. The hospital chain reported a consolidated net profit of ₹103.72 crore, a notable increase from ₹85.61 crore in the previous fiscal year. Consolidated revenue for FY26 reached ₹1,081.24 crore, up from ₹950.83 crore in FY25.

Dividend and Board Appointments

The company's Board of Directors recommended a final dividend of Re. 0.45 per equity share, pending shareholder approval. In addition to the financial results, the board proposed new director appointments, including Mr. Tapan Mitra as Additional Director and Dr. Girdhar J. Gyani as Independent Director. Shareholder consent will also be sought for the re-appointment of statutory auditors, T R Chadha & Co LLP, for a second term.

Impact of New Labour Codes

Artemis Medicare noted an increase of ₹3.07 crore in employee liabilities, primarily due to the implementation of new Labour Codes. This rise in employee benefit costs is a factor that may influence future profitability.

Market Position

Artemis Medicare's FY26 revenue of ₹1,081 crore and profit of ₹103.7 crore position it as a significant player in the healthcare sector. However, larger listed peers like Apollo Hospitals (₹15,778 Cr revenue), Fortis Healthcare (₹7,016 Cr revenue), and Max Healthcare (₹5,137 Cr revenue) operate at a considerably larger scale.

Financial Snapshot

On a standalone basis, revenue from operations grew from ₹936.78 Cr in FY25 to ₹1,060.49 Cr in FY26. Standalone net profit after tax rose from ₹84.79 Cr to ₹103.44 Cr over the same period.